Conversion of carbohydrates in low melting mixtures and Melanoma Inhibitory Activity (MIA) protein inhibitors for the treatment of malignant melanoma [PDF]
Carolin Ruß
openalex +1 more source
A programmable nanoreactor was engineered for precise cGAS‐STING pathway activation in cancer immunotherapy. This strategy bridges targeted tumor DNA damage with DC immunomodulation, providing a translatable platform to unlock innate and adaptive antitumor immunity.
Shuang Liang +14 more
wiley +1 more source
Association between GRIm score and response to nivolumab monotherapy in patients with advanced malignant melanoma. [PDF]
Oksuz S +9 more
europepmc +1 more source
MALIGNANT MELANOMA IN YOUNG PATIENTS: HISTOPATHOLOGIC PARTICULARITIES
openalex +1 more source
CD147/Basigin: From Integrative Molecular Hub to Translational Therapeutic Target
This review conceptualizes CD147 as a fundamental “Energy‐Structure Coupler,” physically bridging metabolic flux (via MCTs) with morphogenetic plasticity (via integrins/MMPs) to drive cancer, infection, and autoimmunity. Addressing the “specificity paradox” that limits current translation, the authors chart a strategic roadmap—spanning logic‐gated ...
Xiang‐Min Yang +2 more
wiley +1 more source
Primary malignant melanoma of the pineal region: illustrative case. [PDF]
Xu J, Hu J, Chen Z.
europepmc +1 more source
Wnt interaction and extracellular release of prominin-1/CD133 in human malignant melanoma cells
Germana Rappa +8 more
openalex +2 more sources
Biomimetic membrane interface engineering constructs functionalized detection platforms by integrating natural cell membranes, synthetic lipids, or hybrid membranes. This strategy effectively reduces background interference and enables efficient target capture and analysis, showing broad applications in circulating tumor cell separation, extracellular ...
Duo Liu +8 more
wiley +1 more source
Diverse radiotherapy fractionation in malignant melanoma: a case report. [PDF]
Shen J, Ge Y, Zhang P, Gao H, Wang L.
europepmc +1 more source
Trojan Horse Strategy: How Biomimetic Nanomedicine Remodels the Tumor Microenvironment
This review focuses on biomimetic nanomedicines for tumor microenvironment (TME) remodeling, covering their diverse biomimetic types, design principles, and mechanisms of immune cell reprogramming and reversal of immunosuppressive microenvironments, with particular emphasis on their application in synergistic immunotherapy.
Wanrong Wang +7 more
wiley +1 more source

